Author Question: A pregnant woman who is HIV positive is taking zidovudine. She is very concerned about her infant ... (Read 79 times)

ec501234 · **on:** Jul 23, 2018

A pregnant woman who is HIV positive is taking zidovudine. She is very concerned about her infant and says, My doctor said they won't even test my baby until she is 2 weeks old. I wish they would do it when she is born. What responses, by the nurse, are indicated?

1. Since you are taking zidovudine, a test at birth will not be accurate.
2. The tests are much more accurate when your baby gets to be 2 weeks old.
3. You can expect your baby to be tested at 1 month of age.
4. Testing will continue until your baby is 1 year old.
5. The most sensitive test is one done at 1 week of age.

Question 2

Certain drugs areproduced and prescribed with a faster process of review. Why did this occur?

1. There was limited knowledge of certain diseases and people were dying.
2. There existed faster authorization of therapeutic drugs that met medical need.
3. Drug development was stagnant and time consuming.
4. The benefits outweighed the risks.

trampas · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

1,2,3,4
Rationale 1: Testing can be done at birth if the mother is not taking zidovudine. If she is taking the medication, the test is not accurate.
Rationale 2: Tests become much more sensitive when the child reaches 2 weeks of age.
Rationale 3: Tests are repeated at 1 month of age.
Rationale 4: Infants are often retested at ages 6 and 12 months.
Rationale 5: A test at 1 week of age is not accurate in this patient's situation.

Global Rationale: Testing can be done at birth if the mother is not taking zidovudine. If she is taking the medication, the test is not accurate. Tests become much more sensitive when the child reaches 2 weeks of age. Tests are repeated at 1 month of age. Infants are often retested at ages 6 and 12 months. A test at 1 week of age is not accurate in this patient's situation.

Answer to Question 2

2

Rationale 1: There was not a limited knowledge about the disease process.
Rationale 2: The production and prescriptions met the medical need based on the rise of incidence ofcertain diseases.
Rationale 3: Drug development was not stagnant. Drug development is time consuming and expensive.
Rationale 4: The risks and benefits were not identified.

Global Rationale: The FDA has made more drugs available to the U.S. public and with a faster process of reviewing using four general approaches. These include priority review, breakthrough therapy, accelerated approval, and fast track. HIV/AIDS drugs were produced and prescribed to meet the challenging or unmet medical need.